• OPEN AN ACCOUNT
Indian Indices
Sensex
73,123.83 -125.56
( -0.17%)
Global Indices
Nasdaq
52,230.09 -658.89
(-1.25%)
Dow Jones
7,644.13 -40.30
(-0.52%)
Hang Seng
62,584.98 -322.86
(-0.51%)
Nikkei 225
10,670.63 -54.40
(-0.51%)
Forex
USD-INR
94.61 0.10
(0.11%)
EUR-INR
106.18 0.08
(0.07%)
GBP-INR
126.70 0.19
(0.15%)
JPY-INR
0.60 0.00
(0.70%)

EQUITY - MARKET SCREENER

Indiabulls Limited
Industry :  Diversified - Medium / Small
BSE Code
ISIN Demat
Book Value()
533520
INE126M01010
29.2756122
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
IBULLSLTD
0
7432.74
EPS(TTM)
Face Value()
Div & Yield %
0
2
0
 

contil india ltd
Gufic BioSciences consolidated net profit rises 183.68% in the March 2026 quarter
Jun 01,2026
Net profit of Gufic BioSciences rose 183.68% to Rs 21.90 crore in the quarter ended March 2026 as against Rs 7.72 crore during the previous quarter ended March 2025. Sales rose 22.83% to Rs 251.82 crore in the quarter ended March 2026 as against Rs 205.02 crore during the previous quarter ended March 2025.

For the full year,net profit declined 7.81% to Rs 64.21 crore in the year ended March 2026 as against Rs 69.65 crore during the previous year ended March 2025. Sales rose 15.15% to Rs 944.01 crore in the year ended March 2026 as against Rs 819.81 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales251.82205.02 23 944.01819.81 15
OPM %18.7512.87 -16.0316.60 -
PBDT36.6018.37 99 117.38115.21 2
PBT28.9510.52 175 86.5594.14 -8
NP21.907.72 184 64.2169.65 -8